Vitalhub Corp. (TSE:VHI - Get Free Report)'s stock price was down 0.7% during trading on Thursday . The stock traded as low as C$11.12 and last traded at C$11.14. Approximately 56,284 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 113,660 shares. The stock had previously closed at C$11.22.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the stock. Canaccord Genuity Group boosted their target price on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a "buy" rating in a report on Thursday, January 16th. TD Securities upgraded Vitalhub to a "strong-buy" rating in a research note on Monday, November 25th. Finally, Scotiabank set a C$14.00 target price on shares of Vitalhub and gave the stock an "outperform" rating in a report on Thursday, January 30th. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of C$11.60.
Get Our Latest Research Report on VHI
Vitalhub Stock Performance
The firm's fifty day simple moving average is C$11.30 and its 200 day simple moving average is C$10.12. The firm has a market cap of C$581.49 million, a P/E ratio of 174.84, a P/E/G ratio of 1.18 and a beta of 1.26.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
